Incretin Effect in Patients With Psoriasis and Controls
NCT ID: NCT06064084
Last Updated: 2023-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2011-09-11
2015-09-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Insulin Action in Psoriasis Pathogenesis
NCT06242847
The DIET Trial - Dietetic Intervention in Psoriatic Arthritis
NCT03142503
Glucose Trnsporter and PEDF in Psoriasis
NCT04242082
Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
NCT01687582
Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis
NCT02644954
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Psoriasis
Oral glucose tolerance test
Oral glucose tolerance test 50g
Intravenous isoglycaemic glucose clamp
Intravenous isoglycaemic glucose clamp
Liquid Mixed meal test
Liquid Mixed meal test 520 kcal
Control
Age, Sex and BMI matched
Oral glucose tolerance test
Oral glucose tolerance test 50g
Intravenous isoglycaemic glucose clamp
Intravenous isoglycaemic glucose clamp
Liquid Mixed meal test
Liquid Mixed meal test 520 kcal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral glucose tolerance test
Oral glucose tolerance test 50g
Intravenous isoglycaemic glucose clamp
Intravenous isoglycaemic glucose clamp
Liquid Mixed meal test
Liquid Mixed meal test 520 kcal
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Gentofte, Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Filip Krag Knop
Professor, MD
References
Explore related publications, articles, or registry entries linked to this study.
Lauritsen JV, Bergmann N, Junker AE, Gyldenlove M, Skov L, Gluud LL, Hartmann B, Holst JJ, Vilsboll T, Knop FK. Oral glucose has little or no effect on appetite and satiety sensations despite a significant gastrointestinal response. Eur J Endocrinol. 2023 Dec 6;189(6):619-626. doi: 10.1093/ejendo/lvad161.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11031999
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.